PACKAGE LEAFLET: INFORMATION FOR THE USER. Lamisil 1 % cutaneous spray solution Terbinafine hydrochloride

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)

Liquid Medical Oxygen Medicinal gas, cryogenic Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER. Exembol Multidose 100 mg/ml concentrate for solution for infusion. Argatroban Monohydrate

Lotrimin vs lamisil for athletes foot

Before you use KINERET. When you must not use it. Do not use KINERET if you have. using a medicine known as tumour necrosis factor (TNF) antagonist.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Medical Oxygen/Carbon Dioxide Mixtures Oxygen, Carbon Dioxide, Medicinal gas, compressed

Before you use. When you must not use it

Compressed Medical Oxygen Medicinal gas, compressed

Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)

CSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER

HEALTH AND HYGIENE Safety Data Sheet

Package leaflet: Information for the user Finasteride 5 mg Film-coated Tablets Finasteride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Neophyr 225 ppm mol/mol medicinal gas, compressed

MATERIAL SAFETY DATA SHEET

Safety data sheet MICRO AIR Revision date : 2009/05/20 Page: 1/6

SAFETY DATA SHEET According to Regulation (CE) n 1907/2006

Elements for a public summary

TEV-TROPIN [somatropin (rdna origin) for injection] 5 mg & 10 mg

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet

SAFETY DATA SHEET according to 1907/2006/EC, Article 31

PACKAGE LEAFLET FOR: AMX 10 mg/ml Concentrate for solution for fish treatment

Spartan Chemical Company, Inc. Material Safety Data Sheet

SAFETY DATA SHEET GRF83 GRANGERS PERFORMANCE REPEL

Safety Data Sheet MasterProtect EL 850 TB ultradeep also SILFLEX TB ULTRA DEEP Revision date : 2011/06/10 Page: 1/6

Safety data sheet GLENIUM 3030 NS Revision date : 2009/03/30 Page: 1/5

MATERIAL SAFETY DATA SHEET

Package leaflet: Information to the user. Medicinsk Lustgas Air Liquide 100%, medicinal gas, liquefied. Nitrous oxide 100% (medicinal laughing gas)

SAFETY DATA SHEET. Tarkett Repair Kit - Putty 20gr and Putty 100gr

Safety Data Sheet 1533BR

w/w % EC-nr (NLP) <2.5 Acute Tox. 4, Skin Corr. 1A <0.01

SAFETY DATA SHEET Washer fluid concentrated

SAFETY DATA SHEET GRF76 GRANGERS FOOTWEAR REPEL

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Safety Data Sheet According to EG 1907/2006

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Caring for a balloon retained gastrostomy tube (Pexact or RIG tube) GI Unit Patient Information Leaflet

Propylene Glycol Diacetate. Propylene Glycol Diacetate 1,2-Diacetoxypropane; Propylene diacetate; 1,2-Propanediol diacetate Formula C 7 H 12 O 4

SAFETY DATA SHEET Linen Fresh Ironing Water

SAFETY DATA SHEET Adhesion Promoter

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Safety data sheet NAVITAS 33 Revision date : 2009/03/26 Page: 1/5

Package leaflet: Information for the user. Medicinal Oxygen Air Liquide 100%, Medicinal gas, compressed. Oxygen 100% (O 2 )

SAFETY DATA SHEET CARLUBE DOT 4 BRAKE FLUID

Material Safety Data Sheet Extinguishing agent Forrex AB Identification of the chemical and responsible company

Big Wipes 4x4 Health & Safety Data Sheet

MATERIAL SAFETY DATA SHEET

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

SAFETY DATA SHEET Cleenol Lift Cream Cleaner

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

SAFETY DATA SHEET Rozone SW-6

Spartan Chemical Company, Inc. Material Safety Data Sheet

SAFETY DATA SHEET ARALDITE RAPID CERAMIC AND GLASS HARDENER

SAFETY DATA SHEET Carlube AdBlue

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

SAFETY DATA SHEET ADI-FLOW Dry

SAFETY DATA SHEET SAFOR

Insect Repellent Wipe Version number: 1.0 Date: 13 June 2012 Supercedes: n/a

MATERIAL SAFETY DATA SHEET BERGAMOT OIL

MATERIAL SAFETY DATA SHEET Page 1 of 5.

Quick Strike Insecticide Safety Data Sheet

Package leaflet: Information for the patient

MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

MATERIAL SAFETY DATA SHEET

PEUGEOT PROTECT Tyre & Trim Dressing. PEUGEOT PROTECT Tyre & Trim Dressing, 400ml

Material Safety Data Sheet Version 2.0 Creation date: 01/02/2013

Safety Data Sheet MasterPozzolith 210 also POZZOLITH 210 Revision date : 2013/12/17 Page: 1/6

SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006 Version 1.0 Revision Date

CAS-No. EC-No. Index-No. Concentration Cetrimonium chloride % Water %

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification 1 / 8

MATERIAL SAFETY DATA SHEET According to 1907/2006/EC REACH and 1272/2008/EC

SAFETY DATA SHEET. Product name: G9 HIGH LEVEL SURFACE DISINFECTANT - CONCENTRATE

MATERIAL SAFETY DATA SHEET SDS/MSDS. Buffer Solution ph 9.2 (Borate)

Safety Data Sheet. according to Regulation (EC) No 1907/2006. KÖSTER Polysil TG 500. Revision date: Product code: M111 Page 1 of 5

MATERIAL SAFETY DATA SHEET

Causes serious eye irritation. Harmful to aquatic life with long lasting effects.

SAFETY DATA SHEET GREASE MOLYBDENUM

SUPER KLEEN MULTI-PURPOSE

SAFETY DATA SHEET FABRIC MAGIC STAIN REMOVER WIPES FM005

SAFETY DATA SHEET AUTO FIN SPEED SHINE DETAILER

SAFETY DATA SHEET Liquid Ice Melt

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Selective Weed Control Safety Data Sheet

Safety data sheet according to 1907/2006/EC, Article 31

SAFETY DATA SHEET FARECLA PROFILE RIB & DINGHY CLEANER F014. Xi: R38; Xi: R41 Skin Corr. 1A: H314 Irritating to skin. Risk of serious damage to eyes.

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

Safety Data Sheet REMEDY OLIVAMINE ANTIMICROBIAL CLEANSER

SAFETY DATA SHEET Redex AdBlue

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

2 Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

SAFETY DATA SHEET. Section 1: Identification of the substance/mixture and of the company/undertaking. Section 2: Hazards identification

ETHYL GLYCOL ACETATE

SAFETY DATA SHEET PESTSHIELD CAT LITTER TRAY SANITISER PS0034. This product has no classification under CHIP.

SAFETY DATA SHEET ULTIMEG 2000/380 HF

Safety Data Sheet FRAGRANCED SHAMPOO & BODY WASH

CRC Industries Europe bvba. 12, Bld des Martyrs de Chateaubriant F Argenteuil Cédex. CRC Industries Europe bvba

Transcription:

The PL includes alternative texts for different legal status in different countries as follows: - Boxed texts are only applicable for OTC versions. - [Grey-shaded texts in brackets] are only applicable for prescription versions. For OTC use in Sweden, please refer to the approved Swedish package leaflet published on our Webb site. PACKAGE LEAFLET: INFORMATION FOR THE USER Lamisil 1 % cutaneous spray solution Terbinafine hydrochloride [Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.] Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Always use this medicine exactly as described in this leaflet or as your pharmacist has told you. Keep this leaflet. You may need to read it again. Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your pharmacist. This includes any possible side effects not listed in this leaflet. You must talk to a doctor if you do not feel better or if you feel worse after 2 weeks. What is in this leaflet: 1. What Lamisil Spray is and what it is used for 2. What you need to know before you use Lamisil Spray 3. How to use Lamisil Spray 4. Possible side effects 5. How to store Lamisil Spray 6. Contents of the pack and other information 1. WHAT LAMISIL SPRAY IS AND WHAT IT IS USED FOR Lamisil Spray is an antifungal agent for use on the skin. It works by killing the fungi causing skin problems. Lamisil Spray is used to treat: Athlete s foot (tinea pedis) Dhobie or jock itch (tinea cruris) Ringworm (tinea corporis) A yeast infection of the skin called pytiriasis versicolor.

If you are not sure about the cause of your infection, please talk to your doctor or pharmacist before using Lamisil Spray and they will advise you. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE LAMISIL SPRAY Do not use Lamisil Spray If you are allergic to terbinafine or any of the other ingredients of this medicine (listed in section 6 and at the end of Section 2). Tell your doctor or pharmacist if this applies to you and do not use Lamisil Spray. Warnings and precautions Talk to your doctor or pharmacist before using Lamisil Spray. Lamisil Spray is for external use only. Do not use it in the mouth or swallow it. Avoid contact of the spray with your face, eyes or damaged skin where alcohol could be irritating. If the spray accidentally gets into your eyes, rinse thoroughly with running water. If any discomfort persists, see your doctor. Do not breathe in the spray. Lamisil Spray contains alcohol. Keep it away from naked flames Children and adolescents Children and adolescents under 18 should not use Lamisil Spray. Other medicines and Lamisil Spray Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. Do not apply other medicines or treatments to the affected area (including any you have bought without a prescription) at the same time as Lamisil Spray. Pregnancy breast-feeding and fertility If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Lamisil Spray should not be used during pregnancy unless clearly necessary. Do not use Lamisil Spray while breast-feeding. Do not allow infants to come into contact with any treated areas, including the breasts. Driving and using machines The use of Lamisil Spray does not affect your ability to drive and use machines. Lamisil Spray contains propylene glycole Lamisil Spray contains propylene glycol which may cause skin irritation. 3. HOW TO USE LAMISIL SPRAY Always use this medicine exactly as described in this leaflet or as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is to apply the spray once or twice a day for one week as indicated below. Directions for use: Adults Clean and dry the affected skin and surrounding area, and wash your hands.

Remove the cap from the spray bottle. Before using for the first time, press the pump a few times until you achieve an even spray. Spray enough of the solution to thoroughly wet the affected skin and surrounding area. You can hold the spray bottle upright or upside down to get to affected areas more easily. Replace the cap on the bottle. Wash your hands after using the spray, otherwise you may spread the infection to other parts of your own skin or to other people. How often and how long should you use Lamisil spray Apply the spray once or twice a day on the affected area as shown below unless your doctor tells you otherwise: Athlete s foot: apply once a day for one week Dhobie or jock itch and ringworm: apply once a day for one week Yeast infection (pityriasis versicolor): apply twice a day for one week. Your skin should start to improve within a few days, but it may take up to 4 weeks for your skin to regenerate completely. If you have not noticed any signs of improvement within 2 weeks after applying Lamisil Spray, ask your doctor or pharmacist for advice. Discard any remaining spray 12 weeks after first opening. To help with treatment Keep the affected area clean by washing it regularly. Dry it carefully without rubbing, but dabbing it gently. Although the area may be itchy, try not to scratch it because this could cause more damage and slow the healing process or spread the infection. Use your own towel and clothes and do not share them with other people because these infections can be passed on easily. Wash your clothes and towels frequently to protect yourself from reinfection. If you forget to use Lamisil Spray If you forget an application of the spray, apply it as soon as possible and then carry on as normal. If you only remember at the time of the next application, just apply the usual amount and carry on as normal. Do not use a double dose to make up for a forgotten dose. Use the spray as indicated. This is important as by missing applications the infection risks returning. If you accidentally swallow some of the product Tell your doctor immediately who will advise you what to do. Alcohol content has to be considered. If you accidentally get the product in your eyes Rinse your eyes thoroughly with running water. See your doctor if you are still in any discomfort. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them.

People may be allergic to Lamisil Spray, which could cause swelling and pain, skin rashes or hives. This has been reported with unknown frequency (cannot be estimated from the available data). If you experience these particular symptoms, stop using the solution and tell your doctor or pharmacist immediately. The following side effects have also been reported: Common (may affect up to 1 in 10 people) Skin peeling and itching at the application site Uncommon (may affect up to 1 in 100 people) Skin lesion, scab, skin disorder, pigmentation changes, redness, burning, pain and irritation at the site of application. Rare (may affect up to 1 in 1,000 people) Dry skin, eczema, condition aggravated. If Lamisil Spray is accidentally applied to the eyes, eye irritation may occur. Unknown (frequency cannot be estimated from the available data) Rash Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. You can also report side effects directly via the national reporting system. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE LAMISIL SPRAY Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and the bottle after EXP. The expiry date refers to the last day of that month. Do not store above 30 o C. Do not refrigerate or freeze. Replace the cap on the bottle after use. Discard any remaining spray 12 weeks after first opening. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION What Lamisil Spray contains

The active substance is terbinafine hydrochloride. One gram of Lamisil Spray contains 10 mg of terbinafine hydrochloride (1% w/w). The other ingredients are purified water, ethanol 96%, propylene glycol (E1520), macrogol cetostearyl ether. What Lamisil Spray looks like and contents of the pack Lamisil cutaneous spray solution is a clear, colourless to faintly yellow liquid. Lamisil 1% cutaneous spray solution is available as a 15 or 30 ml bottle with a spray pump. Not all pack sizes maybe marketed. Marketing Authorisation Holder {Name and address} <{tel}> <{fax}> <{e-mail}> Manufacturer {Name and address} <{tel}> <{fax}> <{e-mail}> This leaflet was last revised in 3 March 2015